Common ones reported by the Government of Canada include nausea, vomiting, diarrhea, and loss of appetite, especially when starting the medication or increasing the dose
Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2
For those whose symptoms interfere with daily life, staying on a lower dose for a longer period or even maintaining a reduced dose can improve both adherence and overall tolerability
It's manageable in my opinion. Brittany Quatrochi, an analyst with Edward Jones, said the push among shoppers toward healthier offerings, a cleaner ingredients profile and interest in functional nutrition have all proven to be more influential in forcing food companies to change how they market and innovate than GLP-1s
The question of lifelong treatment with tirzepatide reflects a broader challenge in managing chronic metabolic conditions